Alpha1-proteinase inhibitor (human) 1000mg/vial; lyophilized pwd for IV infusion after reconstitution; preservative-free. Upper respiratory tract infection, UTI, nausea, pain, chills, cough ...
In September 2023, The US Food and Drug Administration has approved Krystal Biotech’s Investigational New Drug (IND) ...
TB Alliance has disclosed new ATP-dependent Clp protease ClpP1P2 complex (Mycobacterium tuberculosis) inhibitors reported to be useful for the treatment of tuberculosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback